<DOC>
	<DOCNO>NCT00421707</DOCNO>
	<brief_summary>This double-blind , placebo-controlled , randomise crossover study investigate efficacy safety GW876008</brief_summary>
	<brief_title>Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<criteria>The subject diagnose IBS consistent Rome II Criteria adapt Appendix 3 protocol The subject normal result flexible sigmoidoscopy , colonoscopy , flexible sigmoidoscopy plus barium enema , accord subject 's age , within 5 year randomization . Otherwise , appropriate procedure ( ) must perform normal result obtain 7day procedure window ( prior randomization ) : If subject &lt; 50 year age colonic examination within 5 year Screening Visit , flexible sigmoidoscopy , colonoscopy must perform . If subject = 50 year age colonic examination within 5 year Screening Visit , colonoscopy flexible sigmoidoscopy plus barium enema must perform . Colonic procedure result must know prior randomization study dispense study medication During twoweek screen phase , subject must conduct self assessment = 10 day 14 day ( 80 % compliance daily IVRS call ) compliance assessment use telephone data entry system As result medical interview , physical examination , evaluation mental state psychiatric history screen investigation physician Subject report stool 7 consecutive day twoweek screen phase responsible considers subject unfit study The subject concurrent illness disability may affect interpretation clinical data , otherwise contraindicate participation clinical study ( e.g. , unstable cardiovascular , autoimmune , renal , hepatic , pulmonary , endocrine , metabolic , gastrointestinal , haematological , neurological condition ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Irritable Bowel Syndrome safety</keyword>
</DOC>